Performance analysis of Leap Therapeutics (LPTX)
Annual Return
Over the past 3 years, LPTX has had an average annual return of -16.16%, underperforming the benchmark SPY, which returned +20.89% annual.
Over the past 5 years, LPTX has had an average annual return of -35.75%, underperforming the benchmark SPY, which returned +12.30% annual.
Since Jan 25, 2017, LPTX has had an average annual return of -33.91%, underperforming the benchmark SPY, which returned +15.03% annual.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -28.69% | -30.55% | -8.03% | -86.10% | +43.97% | +100.91% | -44.01% | -67.94% | -20.61% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -80.60% | -16.90% | -33.90% | +35.90% | -9.43% | -20.83% | +2.63% | -5.13% | +56.76% | -1.72% | +357.89% | -28.69% | |
| 2024 | -27.51% | -7.07% | -4.79% | +16.57% | -21.57% | -19.42% | +9.24% | +35.66% | -11.38% | +45.57% | -20.38% | -3.43% | -30.55% |
| 2023 | +47.64% | -14.30% | -40.28% | +15.01% | +127.31% | -64.84% | -12.31% | -18.62% | -38.03% | +6.25% | +52.94% | +84.27% | -8.03% |
| 2022 | -40.13% | +2.59% | -12.09% | -26.28% | -16.27% | +6.48% | -9.57% | +36.58% | -38.02% | -3.30% | -28.99% | -25.49% | -86.10% |
| 2021 | +3.53% | -0% | -18.45% | -9.97% | -5.28% | +1.26% | -13.42% | +21.08% | +133.18% | -30.42% | -6.45% | +24.12% | +43.97% |
| 2020 | +70.53% | +26.17% | -34.44% | +38.61% | +8.22% | -11.81% | -1.92% | -15.11% | +13.78% | -1.51% | -17.94% | +40.62% | +100.91% |
| 2019 | -2.51% | -19.99% | +19.85% | -9.08% | -14.70% | +23.41% | +26.26% | -33.18% | -22.49% | +0% | -38.48% | +55.57% | -44.01% |
| 2018 | +7.05% | -1.05% | +25.56% | -17.47% | +35.77% | -3.23% | -16.88% | -1.47% | +5.69% | -42.10% | -17.97% | -45.93% | -67.94% |
| 2017 | -18.28% | +11.16% | +28.57% | -22.77% | -6.63% | -0.59% | -1.22% | -10.62% | -1.72% | +2.97% | +9.86% | -3.41% | -20.61% |
Drawdown analysis of Leap Therapeutics (LPTX)
The maximum drawdown for the LPTX was -99.76%, occurring on Aug 14, 2025. This drawdown has not yet recovered.
The current LPTX drawdown is -97.95%.
Since Jan 25, 2017 LPTX has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 2 times
- 30% or more: 2 times
- 20% or more: 3 times
- 10% or more: 3 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.76% | Apr 12, 2018 | 1845 | Aug 14, 2025 | Ongoing | Ongoing | Ongoing |
| -46.34% | Mar 8, 2017 | 157 | Oct 19, 2017 | 114 | Apr 5, 2018 | 271 |
| -28.80% | Jan 26, 2017 | 5 | Feb 2, 2017 | 22 | Mar 7, 2017 | 27 |
| -9.00% | Apr 5, 2018 | 1 | Apr 6, 2018 | 4 | Apr 12, 2018 | 5 |